Russell Kohl, MD, FAAFP, elected president of American Health Quality Association

Austin, Texas – July 10, 2018 – Russell Kohl, MD, FAACP, assumed his role as president of the American Health Quality Association (AHQA) at the AHQA Quality Summit on July 9.  Dr. Kohl, the chief medical officer for TMF Health Quality Institute, was voted in as AHQA president-elect at the 2017 conference.

AHQA is an educational, not-for-profit national membership association dedicated to promoting and facilitating fundamental change that improves the quality of health care in America.

AHQA represents Quality Improvement Organizations (QIOs) and other professionals working to improve health care quality and patient safety. As a leading QIO, TMF Health Quality Institute is pleased to have an active role in the association.

As chief medical officer for TMF, Dr. Kohl works to support quality improvement efforts and leads the TMF Innovation Team. As president of AHQA, Dr. Kohl will work on behalf of the QIO program and fellow QIOs to extend programs and initiatives that focus on bettering patient care and health care improvement.

As a family physician, Dr. Kohl strives to identify what is truly important to and for patients, how to measure those things and to improve them in collaboration with everything from solo primary care offices to academic health care systems. He also serves as vice-speaker of the American Association of Family Physicians Congress of Delegates.

About TMF Health Quality Institute

TMF Health Quality Institute focuses on improving lives by improving the quality of health care through contracts with federal, state and local governments, as well as private organizations. For more than 45 years, TMF has helped health care providers and practitioners in a variety of settings improve care for their patients.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.